PATENT CLAIM ANALYSIS

Application Number: 15873255
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "313000"]

Abstract:
Compositions of the invention comprise 1,2-dithiolane, dithiol and related compounds useful as therapeutic agents for the treatment and prevention of diseases and conditions associated with aberrant EGFR activity.

Claim (Index 19):
The method of  claim 17 , wherein the EGFR is a mutant EGFR.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 86.0
- Lexical Diversity: 1.15385
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15873293', '13354556', '12429014', '11169312', '15319637']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7419206403483968
- 35 USC 102 Novelty (BERT): 0.5607783665094798
- Combined Prediction Score: 0.7238064129645051
- Mean Citation Score: 284.493394
- Max Citation Score: 412.86075
- Similarity Product: 363.3248159484118

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test